1. Home
  2. GEOS vs MREO Comparison

GEOS vs MREO Comparison

Compare GEOS & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geospace Technologies Corporation (Texas)

GEOS

Geospace Technologies Corporation (Texas)

SELL

Current Price

$3.40

Market Cap

61.4M

Sector

Industrials

ML Signal

SELL

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

SELL

Current Price

$0.27

Market Cap

50.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GEOS
MREO
Founded
1980
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
50.3M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
GEOS
MREO
Price
$3.40
$0.27
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $1.96
AVG Volume (30 Days)
87.4K
★ 631.8K
Earning Date
11-19-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 16.67
EPS
N/A
★ N/A
Revenue
★ $110,803,000.00
$500,000.00
Revenue This Year
N/A
$59.51
Revenue Next Year
N/A
$2,326.81
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.40
$0.20
52 Week High
$24.01
$2.37

Technical Indicators

Market Signals
Indicator
GEOS
MREO
Relative Strength Index (RSI) 27.92 37.53
Support Level N/A $0.23
Resistance Level $4.80 $0.35
Average True Range (ATR) 0.23 0.02
MACD -0.04 0.00
Stochastic Oscillator 0.70 2.04

Price Performance

Historical Comparison
GEOS
MREO

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: